SCHEMBL4445185

SCHEMBL4445185

CC(C)(C)N1CCN(c2ccc(C(F)(F)F)cc2N)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.64
KDM4E B2RXH2 3/20 0.64
LMNA P02545 2/20 0.64
PKM P14618 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.45
POLB P06746 1/20 0.42
CFTR P13569 1/20 0.40
HTT P42858 2/20 0.40
GAA P10253 2/20 0.40
MAPT P10636 2/20 0.39
HSD17B10 Q99714 2/20 0.38
MEN1 O00255 1/20 0.38
TSHR P16473 1/20 0.38
KMT2A Q03164 1/20 0.38
S100B P04271 1/20 0.38
DHFR P00374 2/20 0.38
NOTUM Q6P988 1/20 0.38
HPGD P15428 1/20 0.37
MAPK1 P28482 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30063002 1.00 ALDH1A1 (0.64) ALDH1A1KDM4ELMNAPKML3MBTL1
SCHEMBL28338201 0.89 ALDH1A1 (0.78) ALDH1A1KDM4ELMNAPKML3MBTL1
SCHEMBL20495516 0.88 ALDH1A1 (0.49) ALDH1A1KDM4ELMNAPKML3MBTL1
SCHEMBL1048147 0.84 KDM4E (0.68) ALDH1A1KDM4ELMNAPKML3MBTL1
SCHEMBL330331 0.82 ALDH1A1 (0.73) ALDH1A1KDM4ELMNAPKML3MBTL1
SCHEMBL5494223 0.82 ALDH1A1 (0.73) ALDH1A1KDM4ELMNAPKML3MBTL1
SCHEMBL16993892 0.81 ALDH1A1 (0.69) ALDH1A1KDM4ELMNAL3MBTL1POLB
SCHEMBL997022 0.81 ALDH1A1 (0.71) ALDH1A1KDM4ELMNAPKML3MBTL1
SCHEMBL1110554 0.81 ALDH1A1 (0.71) ALDH1A1KDM4ELMNAPKML3MBTL1
SCHEMBL1110535 0.81 ALDH1A1 (0.71) ALDH1A1KDM4ELMNAPKML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2132177-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE Novartis Ag (CH) 2009-12-16 EP disclosed
WO-2008106692-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2008-09-04 WO disclosed